Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Wakimoto

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|February 11, 2014
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathyDanos C Christodoulou, Hiroko Wakimoto, Kenji Onoue, et al.
Molecular Systems Biology|June 24, 2010
Dissecting spatio-temporal protein networks driving human heart development and related disordersKasper Lage, Kjeld Møllgård, Steven Greenway, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2012
Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart developmentKasper Lage, Steven C Greenway, Jill A Rosenfeld, et al.
The Journal of Clinical Investigation|June 3, 2024
Increased endothelial sclerostin caused by elevated DSCAM mediates multiple trisomy 21 phenotypesDavid M McKean, Qi Zhang, Priyanka Narayan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2022
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse modelAnna Axelsson Raja, Hiroko Wakimoto, Daniel M DeLaughter, et al.
Plos One|November 27, 2013
A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in miceSabine M Hölter, Mary Stromberg, Marina Kovalenko, et al.
Circulation. Genomic and Precision Medicine|February 16, 2026
<i>ROBO2</i> Variants Associated With Atrial Septal Defect Define a Novel Regulatory ElementSeong Won Kim, Michael Parfenov, Laura Rodriguez-Murillo, et al.
Circulation. Genomic and Precision Medicine|March 27, 2023
Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated CardiomyopathySophie L V M Stroeks, Ida G Lunde, Debby M E I Hellebrekers, et al.
Nature Cardiovascular Research|February 12, 2024
Tbx5 maintains atrial identity in post-natal cardiomyocytes by regulating an atrial-specific enhancer networkMason E Sweat, Yangpo Cao, Xiaoran Zhang, et al.
Circulation|January 28, 2020
Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic CardiomyopathyChristopher N Toepfer, Amanda C Garfinkel, Gabriela Venturini, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|February 11, 2014
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathyDanos C Christodoulou, Hiroko Wakimoto, Kenji Onoue, et al.
Molecular Systems Biology|June 24, 2010
Dissecting spatio-temporal protein networks driving human heart development and related disordersKasper Lage, Kjeld Møllgård, Steven Greenway, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2012
Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart developmentKasper Lage, Steven C Greenway, Jill A Rosenfeld, et al.
The Journal of Clinical Investigation|June 3, 2024
Increased endothelial sclerostin caused by elevated DSCAM mediates multiple trisomy 21 phenotypesDavid M McKean, Qi Zhang, Priyanka Narayan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2022
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse modelAnna Axelsson Raja, Hiroko Wakimoto, Daniel M DeLaughter, et al.
Plos One|November 27, 2013
A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in miceSabine M Hölter, Mary Stromberg, Marina Kovalenko, et al.
Circulation. Genomic and Precision Medicine|February 16, 2026
<i>ROBO2</i> Variants Associated With Atrial Septal Defect Define a Novel Regulatory ElementSeong Won Kim, Michael Parfenov, Laura Rodriguez-Murillo, et al.
Circulation. Genomic and Precision Medicine|March 27, 2023
Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated CardiomyopathySophie L V M Stroeks, Ida G Lunde, Debby M E I Hellebrekers, et al.
Nature Cardiovascular Research|February 12, 2024
Tbx5 maintains atrial identity in post-natal cardiomyocytes by regulating an atrial-specific enhancer networkMason E Sweat, Yangpo Cao, Xiaoran Zhang, et al.
Circulation|January 28, 2020
Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic CardiomyopathyChristopher N Toepfer, Amanda C Garfinkel, Gabriela Venturini, et al.
Pageof 7